| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |